Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis

[1]  H. Kocher,et al.  Pancreatic Cancer , 2019, Methods in Molecular Biology.

[2]  M. Saitoh.  Involvement of partial EMT in cancer progression. , 2018, Journal of biochemistry.

[3]  Xiyun Yan,et al.  CD146 mediates an E-cadherin-to-N-cadherin switch during TGF-β signaling-induced epithelial-mesenchymal transition. , 2018, Cancer letters.

[4]  M. Hidalgo,et al.  Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer , 2018, International journal of cancer.

[5]  T. Furukawa,et al.  Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma , 2018, Scientific Reports.

[6]  P. R. Sharma,et al.  Dual role of Par‐4 in abrogation of EMT and switching on Mesenchymal to Epithelial Transition (MET) in metastatic pancreatic cancer cells , 2018, Molecular carcinogenesis.

[7]  R. Pozzi Mucelli,et al.  Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection , 2018, European Radiology.

[8]  K. Pienta,et al.  Targeting the tumour stroma to improve cancer therapy , 2018, Nature Reviews Clinical Oncology.

[9]  G. Cao,et al.  Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells , 2018, Oncology letters.

[10]  K. Miyazono,et al.  Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells , 2018, Oncogene.

[11]  M. Hidalgo,et al.  Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies , 2018, Investigational New Drugs.

[12]  H. Omri,et al.  Current Opinions on Chemoresistance: An Overview , 2018, Bioinformation.

[13]  Daniele M. Gilkes,et al.  Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies , 2018, Targeted Oncology.

[14]  J. Metz,et al.  A phase I dose escalation trial of nab-paclitaxel and fixed dose radiation in patients with unresectable or borderline resectable pancreatic cancer , 2018, Cancer Chemotherapy and Pharmacology.

[15]  Robert A. Weinberg,et al.  EMT in cancer , 2018, Nature Reviews Cancer.

[16]  Ya'an Kang,et al.  MiR-21-mediated Metabolic Alteration of Cancer-associated Fibroblasts and Its Effect on Pancreatic Cancer Cell Behavior , 2018, International journal of biological sciences.

[17]  S. Vasseur,et al.  Fountain of youth of pancreatic cancer cells: the extracellular matrix , 2018, Cell Death Discovery.

[18]  T. Ohtsuki,et al.  Stromal Versican Regulates Tumor Growth by Promoting Angiogenesis , 2017, Scientific Reports.

[19]  A. Curtis,et al.  Diels Alder‐mediated release of gemcitabine from hybrid nanoparticles for enhanced pancreatic cancer therapy , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Zhuxian Zhou,et al.  Terminating the criminal collaboration in pancreatic cancer: Nanoparticle-based synergistic therapy for overcoming fibroblast-induced drug resistance. , 2017, Biomaterials.

[21]  M. Hoffman.  The Tissue Factor Pathway and Wound Healing , 2017, Seminars in Thrombosis and Hemostasis.

[22]  M. Apte,et al.  Pancreatic stellate cells: what's new? , 2017, Current opinion in gastroenterology.

[23]  A. Curtis,et al.  Thermally triggered theranostics for pancreatic cancer therapy. , 2017, Nanoscale.

[24]  P. Sidaway.  Breast Cancer: Evolution of metastatic disease revealed , 2017, Nature Reviews Clinical Oncology.

[25]  P. Sidaway.  Pancreatic cancer: TCGA data reveal a highly heterogeneous disease , 2017, Nature Reviews Clinical Oncology.

[26]  M. V. Vander Heiden,et al.  Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions , 2017, Nature Communications.

[27]  S. Karim,et al.  Matrix stiffness induces epithelial–mesenchymal transition and promotes chemoresistance in pancreatic cancer cells , 2017, Oncogenesis.

[28]  E. Giovannetti,et al.  Drug resistance in pancreatic cancer: Impact of altered energy metabolism. , 2017, Critical reviews in oncology/hematology.

[29]  S. Perrier,et al.  Development of a Gemcitabine-Polymer Conjugate with Prolonged Cytotoxicity against a Pancreatic Cancer Cell Line. , 2017, ACS macro letters.

[30]  E. Giovannetti,et al.  A mechanopharmacology approach to overcome chemoresistance in pancreatic cancer. , 2017, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[31]  G. Stephanopoulos,et al.  Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors , 2016, Nature Medicine.

[32]  Lizhou Lin,et al.  Role of microenvironmental periostin in pancreatic cancer progression , 2016, Oncotarget.

[33]  Gun Ho Jang,et al.  A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns , 2016, Nature.

[34]  Rachel A. Kudgus,et al.  Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth. , 2016, ACS nano.

[35]  R. Brekken,et al.  Matrix control of pancreatic cancer: New insights into fibronectin signaling. , 2016, Cancer letters.

[36]  S. Ormanns,et al.  Prevailing over T cell exhaustion: New developments in the immunotherapy of pancreatic cancer. , 2016, Cancer letters.

[37]  S. Pothula,et al.  Key role of pancreatic stellate cells in pancreatic cancer. , 2016, Cancer letters.

[38]  E. Cukierman,et al.  Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions. , 2016, Current opinion in cell biology.

[39]  L. Wood,et al.  Pancreatic cancer , 2016, The Lancet.

[40]  Yang Li,et al.  Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adenocarcinoma , 2016, International journal of molecular sciences.

[41]  B. Pasche,et al.  TGFβ Signaling in the Pancreatic Tumor Microenvironment Promotes Fibrosis and Immune Evasion to Facilitate Tumorigenesis. , 2016, Cancer research.

[42]  Umar Mahmood,et al.  Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival. , 2015, Cancer cell.

[43]  R. Salgia,et al.  Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  Ye Chen,et al.  Tumor microenvironment: Sanctuary of the devil. , 2015, Cancer letters.

[45]  Sanjeev Banerjee,et al.  Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer. , 2015, Colloids and surfaces. B, Biointerfaces.

[46]  T. Chiu,et al.  Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine , 2015, Molecular Cancer.

[47]  P. Thompson,et al.  Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in pancreatic cancer. , 2015, Cancer research.

[48]  A. Ashworth,et al.  Assessing the Significance of BRCA1 and BRCA2 Mutations in Pancreatic Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  R. Markwald,et al.  Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer , 2015, Front. Immunol..

[50]  K. Xie,et al.  Pancreatic cancer stromal biology and therapy , 2015, Genes & diseases.

[51]  M. V. Vander Heiden,et al.  Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. , 2015, Cancer research.

[52]  Kirsty Minton.  Extracellular matrix: Preconditioning the ECM for fibrosis , 2014, Nature Reviews Molecular Cell Biology.

[53]  L. Howells,et al.  Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies. , 2014, European journal of cancer.

[54]  Xiaohong Xu,et al.  Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis. , 2014, Cancer research.

[55]  Sarah A Heerboth,et al.  Drug Resistance in Cancer: An Overview , 2014, Cancers.

[56]  Stephen A. Sastra,et al.  Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. , 2014, Cancer cell.

[57]  Umar Mahmood,et al.  Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. , 2014, Cancer cell.

[58]  Gemma K. Alderton.  Microenvironment: An exercise in restraint , 2014, Nature Reviews Cancer.

[59]  Benjamin D. Smith,et al.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.

[60]  T. Adrian,et al.  Frondoside A enhances the antiproliferative effects of gemcitabine in pancreatic cancer. , 2014, European journal of cancer.

[61]  D. Quail,et al.  Microenvironmental regulation of tumor progression and metastasis , 2014 .

[62]  Wai Leong Tam,et al.  The epigenetics of epithelial-mesenchymal plasticity in cancer , 2013, Nature Medicine.

[63]  M. Barcellos-Hoff,et al.  The evolution of the cancer niche during multistage carcinogenesis , 2013, Nature Reviews Cancer.

[64]  N. Chauhan,et al.  Novel Curcumin-Loaded Magnetic Nanoparticles for Pancreatic Cancer Treatment , 2013, Molecular Cancer Therapeutics.

[65]  T. Ohtsuka,et al.  Hypoxia enhances the interaction between pancreatic stellate cells and cancer cells via increased secretion of connective tissue growth factor. , 2013, The Journal of surgical research.

[66]  A. Saftoiu,et al.  Expression of Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptor in Pancreatic Ductal Adenocarcinomas, Neuroendocrine Tumours and Chronic Pancreatitis , 2013, Endoscopic ultrasound.

[67]  K. Ohuchida,et al.  Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells. , 2013, Cancer research.

[68]  Derek S. Chan,et al.  Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer , 2012, Gut.

[69]  M. Ocker,et al.  Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition. , 2012, International journal of oncology.

[70]  T. Hagemann,et al.  The tumor microenvironment at a glance , 2012, Journal of Cell Science.

[71]  R. Chambers,et al.  Coagulation cascade proteinases in lung injury and fibrosis. , 2012, Proceedings of the American Thoracic Society.

[72]  Atsuo Ochi,et al.  Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans. , 2012, The Journal of clinical investigation.

[73]  T. Hibi,et al.  Chemoresistance is associated with cancer stem cell-like properties and epithelial-to-mesenchymal transition in pancreatic cancer cells. , 2012, Anticancer research.

[74]  W. Hop,et al.  Tumour basement membrane laminin expression predicts outcome following curative resection of pancreatic head cancer , 2012, British Journal of Cancer.

[75]  Alexander A. Fingerle,et al.  The role of stroma in pancreatic cancer: diagnostic and therapeutic implications , 2012, Nature Reviews Gastroenterology &Hepatology.

[76]  Gerald C. Chu,et al.  Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.

[77]  Carlos Cuevas,et al.  Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. , 2012, Cancer cell.

[78]  Li-ming Zhu,et al.  Developments in metastatic pancreatic cancer: is gemcitabine still the standard? , 2012, World journal of gastroenterology.

[79]  C. Galbán,et al.  Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. , 2012, The Journal of clinical investigation.

[80]  K. Matsushima,et al.  Pivotal role of the CCL5/CCR5 interaction for recruitment of endothelial progenitor cells in mouse wound healing. , 2012, The Journal of clinical investigation.

[81]  Z. Werb,et al.  The extracellular matrix: A dynamic niche in cancer progression , 2012, The Journal of cell biology.

[82]  A. Redig,et al.  Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression. , 2012, The Biochemical journal.

[83]  Y. Miao,et al.  Transforming growth factor β-induced epithelial-mesenchymal transition increases cancer stem-like cells in the PANC-1 cell line. , 2012, Oncology letters.

[84]  H. Friess,et al.  StellaTUM: current consensus and discussion on pancreatic stellate cell research , 2011, Gut.

[85]  V. Ellenrieder,et al.  Oncogenic transcription factors: cornerstones of inflammation-linked pancreatic carcinogenesis , 2011, Gut.

[86]  H. Höfler,et al.  Tenascin-C Enhances Pancreatic Cancer Cell Growth and Motility and Affects Cell Adhesion through Activation of the Integrin Pathway , 2011, PloS one.

[87]  M. Barbacid,et al.  Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. , 2011, Cancer cell.

[88]  J. Berlin,et al.  Current Treatment Options for Pancreatic Carcinoma , 2011, Current oncology reports.

[89]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[90]  Setsuo Hirohashi,et al.  CXCL17 and ICAM2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis. , 2011, Gastroenterology.

[91]  Laura H. Tang,et al.  Survival after Resection of Pancreatic Adenocarcinoma: Results from a Single Institution over Three Decades , 2011, Annals of Surgical Oncology.

[92]  M. Unno,et al.  Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells. , 2010, Biochemical and biophysical research communications.

[93]  A. Biankin,et al.  Tumorigenesis and Neoplastic Progression Role of Pancreatic Stellate Cells in Pancreatic Cancer Metastasis , 2010 .

[94]  Mikala Egeblad,et al.  Dynamic interplay between the collagen scaffold and tumor evolution. , 2010, Current opinion in cell biology.

[95]  D. Lombardo,et al.  In Vitro and In Vivo Anticancer Activity of a Novel Nano-sized Formulation Based on Self-assembling Polymers Against Pancreatic Cancer , 2010, Pharmaceutical Research.

[96]  A. Lohse,et al.  CCK1 and CCK2 Receptors Are Expressed on Pancreatic Stellate Cells and Induce Collagen Production , 2010, The Journal of Biological Chemistry.

[97]  G. Hart,et al.  Stressing the role of O-GlcNAc: linking cell survival to keratin modification , 2010, Nature Cell Biology.

[98]  M. Omary,et al.  Cytoskeletal keratin glycosylation protects epithelial tissue from injury , 2010, Nature Cell Biology.

[99]  Sejin Han,et al.  Carcinomas contain a matrix metalloproteinase-resistant isoform of type I collagen exerting selective support to invasion. , 2010, Cancer research.

[100]  G. Semenza,et al.  Impaired angiogenesis and mobilization of circulating angiogenic cells in HIF‐1α heterozygous‐null mice after burn wounding , 2010, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[101]  A. Maitra.  Tracking down the hedgehog's lair in the pancreas. , 2010, Gastroenterology.

[102]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[103]  A. Masamune,et al.  Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[104]  Richard O. Hynes,et al.  The Extracellular Matrix: Not Just Pretty Fibrils , 2009, Science.

[105]  J. Shea,et al.  Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[106]  R. Gomis,et al.  Identification of a pancreatic stellate cell population with properties of progenitor cells: new role for stellate cells in the pancreas. , 2009, The Biochemical journal.

[107]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[108]  G. Tuszynski,et al.  Expression of thrombospondin-1 in human pancreatic adenocarcinomas: Role in matrix metalloproteinase-9 production , 2009, Pathology & Oncology Research.

[109]  Helmut Friess,et al.  The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[110]  A. Masamune,et al.  Hypoxia stimulates pancreatic stellate cells to induce fibrosis and angiogenesis in pancreatic cancer. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[111]  D. Goldstein,et al.  Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance. , 2008, Cancer research.

[112]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[113]  K. Kimata,et al.  Impact of the hyaluronan‐rich tumor microenvironment on cancer initiation and progression , 2008, Cancer science.

[114]  Douglas B. Evans,et al.  Cancer-associated stromal fibroblasts promote pancreatic tumor progression. , 2008, Cancer research.

[115]  A. Vincent-Salomon,et al.  A “class action” against the microenvironment: do cancer cells cooperate in metastasis? , 2008, Cancer and Metastasis Reviews.

[116]  D. Tuveson,et al.  Dynamics of the immune reaction to pancreatic cancer from inception to invasion. , 2007, Cancer research.

[117]  H. Cui,et al.  Hypoxia-inducible factor-1 (HIF-1) is involved in the regulation of hypoxia-stimulated expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) and MCP-5 (Ccl12) in astrocytes , 2007, Journal of Neuroinflammation.

[118]  T. Wynn,et al.  Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. , 2007, The Journal of clinical investigation.

[119]  Franco Mosca,et al.  Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine. , 2006, Cancer research.

[120]  H. Friess,et al.  Hedgehog signaling in the normal and diseased pancreas. , 2006, Pancreas.

[121]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[122]  G. Christofori,et al.  Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment , 2006, Cellular and Molecular Life Sciences CMLS.

[123]  Kennichi Satoh,et al.  Ellagic acid blocks activation of pancreatic stellate cells. , 2005, Biochemical pharmacology.

[124]  K. Aterman.  The parasinusoidal cells of the liver: A historical account , 1986, The Histochemical Journal.

[125]  M. Apte,et al.  Mechanisms of Pancreatic Fibrosis , 2005, Digestive Diseases.

[126]  Robert Jaster,et al.  Molecular regulation of pancreatic stellate cell function , 2004, Molecular Cancer.

[127]  T. Oda,et al.  Overexpression of TGF-β by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer , 2004, British Journal of Cancer.

[128]  L. V. Williams,et al.  Tissue repair and the dynamics of the extracellular matrix. , 2004, The international journal of biochemistry & cell biology.

[129]  S. Pastorino,et al.  Hypoxia Selectively Inhibits Monocyte Chemoattractant Protein-1 Production by Macrophages1 , 2004, The Journal of Immunology.

[130]  P. Comoglio,et al.  Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. , 2003, Cancer cell.

[131]  R. Jaster,et al.  Extracellular signal regulated kinases are key mediators of mitogenic signals in rat pancreatic stellate cells , 2002, Gut.

[132]  D. Whitcomb,et al.  Hereditary pancreatitis: a model for inflammatory diseases of the pancreas. , 2002, Best practice & research. Clinical gastroenterology.

[133]  V. Grégoire,et al.  Role of deoxycytidine kinase (dCK) activity in gemcitabine's radioenhancement in mice and human cell lines in vitro. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[134]  M. Korsten,et al.  Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis , 2002, Gut.

[135]  G. Adler,et al.  TGFβ-induced fibrogenesis of the pancreas , 2002, International journal of gastrointestinal cancer.

[136]  C. Hill,et al.  Loss of Smad4 Function in Pancreatic Tumors , 2001, The Journal of Biological Chemistry.

[137]  B. Rollins,et al.  Wound Healing in MIP-1α−/− and MCP-1−/− Mice , 2001 .

[138]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[139]  L. Matrisian,et al.  Tumor progression: Defining the soil round the tumor seed , 2001, Current Biology.

[140]  B. Rollins,et al.  Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice. , 2001, The American journal of pathology.

[141]  G. Adler,et al.  Effects of fibrogenic mediators on the development of pancreatic fibrosis in a TGF-beta1 transgenic mouse model. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[142]  R. Monette,et al.  Increased expression of bioactive chemokines in human cerebromicrovascular endothelial cells and astrocytes subjected to simulated ischemia in vitro , 1999, Journal of Neuroimmunology.

[143]  Erkki Ruoslahti,et al.  Fibronectin Matrix Regulates Activation of RHO and CDC42 GTPases and Cell Cycle Progression , 1998, The Journal of cell biology.

[144]  R. Schmid,et al.  Identification, culture, and characterization of pancreatic stellate cells in rats and humans. , 1998, Gastroenterology.

[145]  T. Gress,et al.  Extracellular matrix is reduced by inhibition of transforming growth factor beta1 in pancreatitis in the rat. , 1997, Gastroenterology.

[146]  R. Hruban,et al.  p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. , 1994, Cancer research.

[147]  A. Andrén-sandberg,et al.  Pancreatitis and the risk of pancreatic cancer , 1993 .

[148]  A. Andrén-sandberg,et al.  Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. , 1993, The New England journal of medicine.

[149]  H. Dvorak.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[150]  Y. Hotta,et al.  Morphological studies on a vitamin A-storing cell and its complex with macrophage observed in mouse pancreatic tissues following excess vitamin A administration. , 1982, Okajimas folia anatomica Japonica.

[151]  DIAGNOSTIC AND THERAPEUTIC IMPLICATIONS , 1978 .

[152]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[153]  P. Richard,et al.  [Neoplastic aspect of a case of interstitial pulmonary fibrosis]. , 1955, Laval medical.

[154]  K. Themel,et al.  Die Bedeutung tuberkulöser Narben für die Entstehung des peripheren Lungenkarzinoms , 1955 .

[155]  K. Themel,et al.  [The role of tuberculous scars in the pathogenesis of peripheral lung carcinoma; a contribution to the symptomatology of cancer of the pulmonary scars]. , 1955, Deutsche Medizinische Wochenschrift.